Sleep Disorders Trial, Recruiting NCT05816304 Sponsor: University Health Network, Toronto Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT05816304
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who work in healthcare and have likely insomnia, shown by a score of 16 or lower on a sleep assessment tool called the Sleep Condition Indicator (SCI)
  • People who consider themselves frontline healthcare workers involved in directly managing patients
  • People who have access to a mobile phone or a computer with an internet connection

Who may not be able to join:

  • People whose healthcare provider has determined they urgently need CBT (a type of talking therapy) treatment right away
  • People who have already received CBT treatment within the past 3 months
  • People who are currently taking part in other psychological treatments or drug trials at the same time as this study
  • People who have reported having other sleep-related conditions, such as sleep apnea or restless legs syndrome
  • People who have serious medical or psychiatric conditions, such as life-threatening illnesses (for example, cancer), neurological conditions (for example, epilepsy), severe depression, or active thoughts of suicide

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mandeep Singh, MD, FRCPC, Associate Professor, Department of Anesthesiology and Pain Medicine, Toronto Western Hospital, UHN

Phone: 416-603-5118

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
16 June 2023
Est. completion
31 December 2024

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Assessing changes in the nature and severity of insomnia:

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov